(Q42769499)

7 November 2017

Evidence for acute neurotoxicity after chemotherapy (English)

1 reference

7 November 2017

1 reference

1 reference

1 reference

10

Ludwig Kappos

1 reference

7 November 2017

8

Gavin Giovannoni

1 reference

7 November 2017

7

Bob Lowenberg

1 reference

7 November 2017

Axel Petzold

1

1 reference

7 November 2017

Tjeerd Mondria

2

1 reference

7 November 2017

Jens Kuhle

3

1 reference

7 November 2017

Maria A Rocca

4

1 reference

7 November 2017

Jan Cornelissen

5

1 reference

7 November 2017

Peter te Boekhorst

6

1 reference

7 November 2017

Massimo Filippi

9

1 reference

7 November 2017

Rogier Hintzen

11

1 reference

7 November 2017

1 December 2010

1 reference

7 November 2017

1 reference

7 November 2017

68

1 reference

7 November 2017

6

1 reference

7 November 2017

806-815

1 reference

Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis

7 November 2017

1 reference

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

21 January 2018

1 reference

Chemobrain: is systemic chemotherapy neurotoxic?

21 January 2018

1 reference

CNS complications of radiotherapy and chemotherapy

21 January 2018

1 reference

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

A specific ELISA for measuring neurofilament heavy chain phosphoforms.

21 January 2018

1 reference

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

21 January 2018

1 reference

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

21 January 2018

1 reference

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

21 January 2018

1 reference

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

21 January 2018

1 reference

The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

Brain atrophy in children undergoing systemic chemotherapy for extracranial solid tumors.

21 January 2018

1 reference

Quantitative assessment of cerebral atrophy during and after treatment in children with acute lymphoblastic leukemia.

21 January 2018

1 reference

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

21 January 2018

1 reference

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments

21 January 2018

1 reference

Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms

21 January 2018

1 reference

Chemotherapy and cognition: effects, potential mechanisms, and management

21 January 2018

1 reference

Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results.

21 January 2018

1 reference

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

21 January 2018

1 reference

Neurofilament ELISA validation.

21 January 2018

1 reference

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

21 January 2018

1 reference

Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology

21 January 2018

1 reference

The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury

21 January 2018

1 reference

Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport

21 January 2018

1 reference

Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection

21 January 2018

1 reference

A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia.

21 January 2018

1 reference

21 January 2018

1 reference

Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro

21 January 2018

1 reference

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.

21 January 2018

1 reference

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?

21 January 2018

1 reference

Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype

21 January 2018

1 reference

Bone marrow transplantation: does it stop MS progression?

21 January 2018

1 reference

Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury

21 January 2018

1 reference

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

Neurocognitive interventions for children and adolescents surviving cancer

21 January 2018

1 reference

Neurocognitive outcomes in survivors of childhood cancer

21 January 2018

1 reference

What is the effect of systemic anticancer treatment on cognitive function?

21 January 2018

1 reference

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

21 January 2018

1 reference

Multiple sclerosis clinical trials: old and new challenges

21 January 2018

1 reference

A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22169

1 reference

7 November 2017

1 reference